Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IL › Decatur › NPI 1285856278
Physician

Bairsetty, Adarsh

Bairsetty, Adarsh was paid $350K by Medicaid between Jan 2018 and Oct 2024, across 12 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 73% of everything it billed.

33Billing provider infoBAIRSETTY, ADARSH
DECATUR, IL 62521
33aNPI1285856278assigned 05/02/2007
28Total paid$350K
24GClaims8,997
24DCodes billed12
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers

Next to other Family Medicine Physician providers in Illinois

Rank by total paid#310 of 2,947
Median peer was paid$43K
This provider vs. median8.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$5.0K$10K$15K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20182,023$63K
20191,496$54K
2020861$32K
2021924$38K
20221,248$51K
20231,389$56K
2024incomplete1,056$56K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 73% 5,824 5,134 $254K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 6.4% 322 286 $22K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 5.7% 1,282 1,134 $20K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 3.3% 491 370 $11K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 2.7% 279 269 $9K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 2.5% 209 184 $9K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 2.1% 104 95 $7K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1.8% 273 178 $6K
87428 1.4% 79 78 $5K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.4% 96 95 $5K
87807 <1% 12 12 $120.72
81002 <1% 26 22 $62.90

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.